Organigram Global Inc. (OGI)
NASDAQ: OGI · Real-Time Price · USD
1.680
-0.020 (-1.18%)
At close: Dec 31, 2025, 4:00 PM EST
1.670
-0.010 (-0.59%)
After-hours: Dec 31, 2025, 7:57 PM EST
Organigram Global Revenue
Organigram Global had revenue of 70.79M CAD in the quarter ending June 30, 2025, with 72.41% growth. This brings the company's revenue in the last twelve months to 223.82M, up 38.47% year-over-year. In the fiscal year ending September 30, 2024, Organigram Global had annual revenue of 159.84M, down -1.11%.
Revenue (ttm)
223.82M CAD
Revenue Growth
+38.47%
P/S Ratio
1.22
Revenue / Employee
196,506 CAD
Employees
1,139
Market Cap
227.45M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 159.84M | -1.80M | -1.11% |
| Sep 30, 2023 | 161.64M | 15.83M | 10.86% |
| Aug 31, 2022 | 145.81M | 66.65M | 84.19% |
| Aug 31, 2021 | 79.16M | -7.63M | -8.79% |
| Aug 31, 2020 | 86.80M | 6.38M | 7.94% |
| Aug 31, 2019 | 80.41M | 67.98M | 546.98% |
| Aug 31, 2018 | 12.43M | -377.00K | -2.94% |
| Aug 31, 2017 | 12.81M | 550.75K | 4.49% |
| Aug 31, 2016 | 12.26M | 11.27M | 1,142.07% |
| Aug 31, 2015 | 986.68K | - | - |
| Feb 28, 2014 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
OGI News
- 1 day ago - Organigram Extends Innovation Investment with Phylos - Business Wire
- 10 days ago - Organigram: Premium Pivot Signals Further Margin Expansion - Seeking Alpha
- 12 days ago - 3 Best Cannabis Stocks: Will They Fly High Again Post Trump Schedule III? - Seeking Alpha
- 16 days ago - Organigram Global Inc. (OGI:CA) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Organigram Reports Record Fourth Quarter and Fiscal 2025 Results - Business Wire
- 27 days ago - Organigram to Report Fourth Quarter Fiscal 2025 Results on December 16, 2025 - Business Wire
- 5 weeks ago - Organigram Announces Appointment of Chief Executive Officer - Business Wire
- 5 weeks ago - Sell Village Farms And Buy Organigram - Seeking Alpha